Delivery Order SPE2DB22D3004-SPE2DB24FQA03

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 10 mg capsules. The award, with a ceiling value of $1,292.35, is a delivery order under an Indefinite Delivery Contract (IDC) held by the parent company Cencora, Inc. (doing business as AmerisourceBergen) with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 60 mg capsules to the Defense Logistics Agency (DLA). The delivery order, valued at $1,293.00, was issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse (lisdexamfetamine dimesylate) 10 mg capsules. The $5,556.76 Firm Fixed Price Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC enables DLA to efficiently procure a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Vyvanse 30 mg capsules. The $1,150.57 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,664.76, is for the delivery of Vyvanse 30 mg capsules to the government. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. The IDC allows the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse (lisdexamfetamine) 40 mg capsules in 100-count bottles. The $3,273.89 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,486.46 firm-fixed-price delivery order contract is for the supply of 4,567,299,122 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,115.61 to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, to provide 100 units of the prescription drug Vyvanse 60 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the supply of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,645.33 delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no...
This federal contract award is for the delivery of Vyvanse 10 mg capsules to the Defense Logistics Agency (DLA), a combat support agency of the U.S. Department of Defense. The $1,318.93 contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, on a Firm Fixed Price basis. The award is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. This...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQA03
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Vyvanse 10 mg capsules. The contract has a ceiling value of $2,783.02 and is structured as a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This particular order is for a specific pharmaceutical product and does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen's extensive supply chain and expertise in pharmaceutical distribution allow the company to efficiently manage the logistics of providing critical medical products to the U.S. government.

Generated 7/16/24, 12:16 PM